High Cholesterol News and Research

RSS

Childhood obesity prescriptions for GLP-1 drugs surge in the U.S.

Although the number of US children under age 12 with obesity being prescribed the weight loss drugs Saxenda, Wegovy, and Zepbound remains low, the number is 310 times higher in June 2026 than it was in 2019, when the drugs were initially prescribed, a new study shows.

4 Sep 2026

CAC-based statin initiation shows no difference in major cardiovascular events

There was no difference in major cardiovascular events when statin initiation was based on coronary artery calcium compared with traditional risk factor assessment, according to results presented in a Hot Line session today at ESC Congress 2026.

31 Aug 2026

Routine referral of prostate cancer patients to a cardiovascular specialist fails to cut cardiac events

Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy.

31 Aug 2026

Atorvastatin reduces major cardiovascular events but misses disability-free survival goal

Atorvastatin reduced major cardiovascular events by 30% in older people without known cardiovascular disease, diabetes or dementia, but did not significantly improve disability-free survival, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.

29 Aug 2026

Pacibekitug safely reduces inflammatory biomarkers in kidney disease patients

The interleukin-6 (IL-6) antibody, pacibekitug, produced sustained reductions in inflammatory biomarkers in patients with chronic kidney disease at high inflammatory risk, according to results from the phase II TRANQUILITY trial presented in a Hot Line session today at ESC Congress 2026.

29 Aug 2026

Study: Nearly 8 out of 10 young adults have cardiovascular-kidney-metabolic syndrome

A new scientific study found that nearly 8 out of 10 young adult participants, average age 23 years, had cardiovascular-kidney-metabolic syndrome (CKM syndrome), according to new independent research published today in Circulation: Population Health and Outcomes, a peer-reviewed scientific journal of the American Heart Association.

20 Aug 2026

Alzheimer's markers show crucial differences across diverse global populations

Established Alzheimer's markers are also detected in blood samples from Nigeria and Tanzania. But other proteins in the blood differ from those seen in a comparable group in Canada.

13 Aug 2026

Tadalafil may increase glaucoma risk in men with enlarged prostates

An erectile dysfunction drug that is also used to treat symptoms like sudden urgency and frequency, which are associated with an enlarged prostate in men, may heighten the risk of the serious eye condition, glaucoma, finds a large comparative study published online in the British Journal of Ophthalmology.

4 Aug 2026

New study advances understanding of dementia after age 90

It may seem natural to assume that people experience cognitive decline after age 90, but until recently, researchers had limited evidence about how advanced age affects the brain.

4 Aug 2026

Modifiable cardiovascular risk factors linked to unstable coronary artery plaques

Cardiovascular risk factors are linked to higher risk of heart disease, but it has been unknown how they are related to abrupt closure of the coronary arteries leading to heart attack and sudden cardiac death.

23 Jul 2026

WHO updates guidelines to reduce risk of dementia worldwide

The World Health Organization (WHO) today released updated guidelines on reducing the risk of cognitive decline and dementia, providing countries with evidence-based recommendations to help prevent or delay the onset of dementia across the life course.

16 Jul 2026

Global study reveals country-specific patterns in dementia risk factors

A major, USC-led study of more than 214,000 older adults across 14 countries and regions finds that the most common controllable risk factors for dementia - such as low education, high blood pressure and smoking - vary widely from country to country, meaning a one-size-fits-all approach to prevention won't work everywhere.

12 Jul 2026

Most hospital readmissions after heart failure are not heart-related

A study reveals that non-cardiovascular medications increase hospital readmission risks in heart failure patients, highlighting the need for better management.

8 Jul 2026

Persistent high cortisol levels increase hypertension risk in patients with adrenal tumors

A major new study, published today in The Lancet Diabetes & Endocrinology has shown that cortisol levels in patients with adrenal tumours are far less stable than previously assumed.

7 Jul 2026

Study tracks why rural residents face higher chronic disease risks

Following the release of data from Assumption Parish earlier this year, researchers at LSU's Pennington Biomedical Research Center have published the first set of data from the Risks Underlying Rural Areas Longitudinal, or RURAL, Heart and Lung study in Franklin Parish. The data book for Franklin Parish is now available to explore.

6 Jul 2026

Some statins may increase erectile dysfunction risk

Research indicates that certain statins, particularly atorvastatin and simvastatin, may elevate the risk of erectile dysfunction, impacting men's health.

6 Jul 2026

Rare genetic condition offers new insights into human aging process

Scientists have discovered a rare genetic condition which causes people to age at a much faster rate, offering fresh insights into the aging process.

30 Jun 2026

Study links cardiovascular risk factors to visual impairment in Latinos

In the U.S., Hispanic/Latino populations are disproportionately at risk for eye diseases like glaucoma and diabetic retinopathy, or vision loss tied to diabetes.

29 Jun 2026

New Florida initiative supports healthier lives for cancer survivors statewide

University of West Florida Assistant Professor of Public Health Dr. Karishma Chhabria Unrue has been awarded a nearly $825,000 grant through the Florida Cancer Innovation Fund to lead a statewide initiative focused on improving the health and well-being of breast and prostate cancer survivors.

27 Jun 2026

Gene linked to lower BMI points researchers toward a new obesity target

A review in Cardiology in Review highlights GPR75, a receptor for 20-HETE, as a promising therapeutic target for obesity and metabolic syndrome. Evidence from genetic studies, cell experiments, and mouse models suggests that blocking this pathway could influence weight gain, insulin resistance, hypertension, inflammation, and vascular dysfunction.

25 Jun 2026